Company: PFSA
Filing Date: 2025-04-03
Form Type: S-4/A
Source: 0001213900-25-028544
Chunk: 207

Company: Profusa, Inc.
Filing Date: 2025-04-03
Form: S-4/A
Chunk 207
---
 but not limited to (i) the dilution caused by existence, exercise and/or conversion of the NorthView Warrants, (ii) significant legal, financial advisor, accounting, banking and consulting fees, fees relating to regulatory filings and notices, SEC filing fees, printing and mailing fees and other costs associated with the Business Combination, and (iii) the dilution caused by any equity issued in connection with the Financings. In addition, in connection with the Profusa bridge financing and NorthView’s working capital financings, investors will be issued shares of which reduce their costs basis to be equivalent to $2.22 per share of New Profusa Common Stock, which is substantially below the redemption price. This incentive structure could also negatively impact the value of the New Profusa Common Stock. The proposed PIPE Convertible Notes and conversion of the Convertible Bridge Loan could result in the issuance of shares of New Profusa Common Stock at an effective price substantially below the redemption price, which could have a negative impact on the value of the New Profusa Common Stock after the closing of the Business Combination. Under the PIPE Subscription Agreement, the conversion of the PIPE Convertible Notes could allow for the PIPE Investors to convert such notes into shares of New Profusa Common Stock at a price substantially below the redemption price which could be received by NorthView public stockholders. Similarly, the holders of Profusa’s Convertible Bridge Loans are expected to convert into shares of Profusa capital stock, and subsequently convert into shares of New Profusa common Stock at an effective price of $2.22 per share. Each of these effective prices is or could be substantially below the redemption price of the NorthView Common Stock. Accordingly, the issuance of shares in connection with the conversion of the PIPE Convertible Notes and conversion of the Convertible Bridge Loan could have a negative impact on the value of the New Profusa Common Stock. Future sales, or the perception of future sales, by New Profusa shareholders in the public market following the Business Combination could cause the market price for New Profusa Common Stock to decline. The sale of shares of New Profusa Common Stock in the public market, or the perception that such sales could occur, could harm the prevailing market price of shares of New Profusa Common Stock. These sales, or the possibility that these sales may occur, also might make it more difficult for New Profusa to sell equity securities in the future at a time and at a price that it deems appropriate. Upon consummation of the Business Combination, a total of approximately